Drug combinations in CLL: ibrutinib, idelalisib and more
A short discussion of the unmet needs of CLL patients
The changing role of nurses in bone marrow biopsies
Exploring and consolidating the CLL world
Lenalidomide and ibrutinib: do they have a future in treating CLL?